Antiproliferative and antifungal activities of essential oils from Erigeron acris root and herb and from Erigeron annuus herb were investigated. The cell viability assay was performed in cultured fi broblasts, cancer cell lines (MCF-7 and MDA-MBA-231), and endometrial adenocarcinoma (Ishikawa) cells as well as colon adenocarcinoma (DLD-1) cells using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The essential oil from E. acris root showed the highest antiproliferative activity in the MCF-7 cell line with an IC 50 value of 14.5 μg/mL. No effect of the essential oil on normal cells at that concentration was found. Antifungal activity against various strains of fi ve Candida species, i.e. C. albicans, C. glabrata, C. tropicalis, C. krusei, and C. parapsilosis, was tested by the microdilution method. It was found that all examined oils can be useful as antifungal agents against the abovementioned species, but the essential oil of E. acris herb was the most active. Their minimum inhibitory concentrations (MIC) ranged from 30 to 0.4 μL/mL. The data presented suggest that essential oils from E. acris and E. annuus possess antifungal activity against Candida spp. and antiproliferative activity against breast cancer MCF-7 cells.
Introduction
Erigeron acris L. (blue fl eabane) is an annual, biennial or rarely perennial herb and Erigeron annuus (L.) Pers. (daisy fl eabane) is an annual plant. Both species, belonging to the family Asteraceae, grow on dry, stony or sandy places. They are distributed almost throughout Europe (Tutin, 1976) . E. acris is occasionally used in health care. In the Spanish province Castellón it has been traditionally used for digestive infusions (de Santayana et al., 2005) . In Italy the roots of E. acris are traditionally used for the treatment of toothache, bruises, and arthritis (Pieroni et al., 2004) . In vitro studies showed that diethyl ether and ethyl acetate extracts from leaves, infl orescences, and roots of E. acris possess antioxidant activity (Nale wajko- Sieliwoniuk et al., 2008) . E. annuus has been used in Chinese folk medicine for the treatment of indigestion, enteritis, epidemic hepatitis, and haematuria (Li et al., 2005) . Root extracts were found to possess antiproliferative activity (Réthy et al., 2007) .
The chemical composition of the essential oils from E. acris and E. annuus is well known. The volatile fractions of E. acris and E. annuus herbs consist of over 60 components. The major constituents are monoterpenes and sesquiterpenes (Nazaruk et al., 2006; Lis et al., 2008) . In the essential oil from the root of E. acris 54 compounds were identifi ed, among them polyacetylenes predominate (Nazaruk and Kalemba, 2009) .
Essential oils, secondary metabolites of plants with volatile properties and specifi c odour, are mixtures of small-molecular chemical compounds, mainly terpenes and phenols, and possess a broad spectrum of biological action. The antispasmodic, analgesic, sedative, and anti-infl ammatory effects of essential oils have been well established (Bakkali et al., 2008) . In some tests they showed cancer suppressive activity and exhibited chemopreventive effi cacy (Edris, 2007 (Bakkali et al., 2008; Kalemba and Kunicka, 2003) . There is increasing interest in antimicrobial plant sources because of the growing resistance of microbes to synthetic compounds. Mycoses are particularly diffi cult to cure. Importantly, there has been a recent increase in infections due to non-albicans Candida spp., such as C. glabrata, C. krusei, C. tropicalis, and C. parapsilosis. The important issue is to search for antifungal agents with alternative mechanisms of action and less toxicity (Singh, 2001) .
So far the activity of essential oils from E. acris and E. annuus has not been studied. Therefore, we sought to examine the infl uence of the oil from E. acris root and herb on cancer cell proliferation, and the toxicity of the oils from E. acris root and herb and E. annuus herb against randomly chosen strains of fungi from the genus Candida.
Results and Discussion
Breast adenocarcinoma cells (MCF-7, MDA-MBA-231), human endometrial adenocarcinoma cells (Ishikawa cell line), and human colon adenocarcinoma cells (DLD-1) (each at 1 · 10 5 cells/well) were treated with the essential oil samples at different concentrations. In the experiment DMSO, added as a solubilizing agent at the maximum content of 0.4%, did not have any signifi cant effect on cell proliferation. Doxorubicin was used as positive control. Its IC 50 value for MCF-7 cells was 44.5 μg/mL. In the MCF-7 cell line, the essential oil from E. acris root showed the highest antiproliferative activity, the IC 50 value being 14.5 μg/ mL. In the other cell lines this value was higher than 50 μg/mL (Table I) . Similar studies were performed on normal skin fi broblasts which were found not to be susceptible to the antipro liferative activity of the essential oils at the concentrations active in the MCF-7 cell line (Table II) .
In case of the essential oil from the herb of E. acris, there was no infl uence on proliferation in all cell lines studied (data not shown).
Compared with doxorubicin, the IC 50 value of essential oil from the root of E. acris is low, so it was recognized as a potentially active agent for breast cancer MCF-7 cells.
Essential oils from E. acris root and herb and from E. annuus herb were tested for their toxicity against various strains of fungi from the genus Candida (C. albicans, C. glabrata, C. tropicalis, C. krusei, C. parapsilosis, and the control strain C. parapsilosis ATCC 22019) applying the serial microdilution method. Table III shows the minimum inhibitory concentration (MIC) and the minimum fungicidal concentration (MFC) for each oil and fungal strain. We conclude that the examined oils can be used as antifungal agents against the species mentioned above. The oil of E. acris herb seems to be most active since its MIC values are relatively low (in the 3.75 -0.4 μL/mL range), however, large variations are observed for individual strains. The activity of the essential oil from the root of E. acris may be due to polyacetylenic compounds, i.e. matricaria and lachnophyllum esters that are the main components. Interestingly, the oil from the herb of the plant with the lowest content of polyacetylenes did not have such an activity. The same effect was observed in extracts from herb and root of E. annuus. Signifi cant antiproliferative and cytotoxic activity was only shown by lipophilic extracts from roots in which polyacetylenic compounds can also be present, but the composition of these extracts unfortunately was not established (Réthy et al., 2007) .
The composition of essential oils is unique due to the variety of chemical structures of their constituents which are deciding their wide activity. The predominant one is strong antimicrobial activity. The mechanism of antifungal action is complex and can involve inhibition of chitin-producing enzymes, membrane leakage or respiratory chain inhibition (Pauli, 2006) . The antimicrobial activity of oils depends on their individual components, but an advantageous synergistic effect of the essential oil constituents has also been observed (Kalemba and Kunicka, 2003) . One of the components responsible for the highest activity of the essential oil from the herb of E. acris seems to be -pinene (15.6% of oil), for which considerable antifungal activity has been demonstrated (Hammer et al., 2003) . Polyacetylenes also possess antifungal activity. Fungitoxic activity of matricaria and lachnophyllum esters and lactones was demonstrated against a phytopathogenic fungus (Vidari et al., 2006) . The essential oils of herb and root of E. acris are probably more active against C. albicans than tea tree oil, a well known antimicrobial agent (Hammer et al., 2003) .
The data presented suggest that essential oils from E. acris and E. annuus possess antifungal activity against various Candida species and antiproliferative activity against breast cancer MCF-7 cells. 
Experimental

Plant material
The fl owering aerial part of E. acris and E. annuus, and the root of E. acris were collected in July 2008 and 2009 in the vicinity of Białystok, Poland. Voucher specimens (EAC 01007 and EAN 01008) have been deposited in the herbarium of the Department of Pharmacognosy, Medical University of Białystok, Poland.
The essential oil was obtained by hydrodistillation from dry, ground plant material, according to the European Pharmacopoeia Commission (2004) and was stored at 4 °C until the examination. The root of E. acris, the herb of E. acris, and the herb of E. annuus contained 1.0%, 0.3%, and 0.15% of essential oil, respectively (w/v, based on dried plant material).
Antiproliferative activity
Reagents: DMSO (dimethyl sulfoxide) and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were provided by Sigma Corp. (St. Louis, USA), as were most other chemicals and buffers used. Dulbecco's minimal essential medium (DMEM) and fetal bovine serum (FBS) used in cell culture were products of Gibco (Grand Island, USA). Glutamine, penicillin, and streptomycin were obtained from Quality Biologicals Inc. (Gaithersburg, USA).
Tissue culture: All studies were performed on normal human skin fi broblasts (CRL-1474), purchased from the American Type Culture Collection (Manassas, VA, USA) and on breast adenocarcinoma cells (MCF-7 and MDA-MBA-231), human endometrial adenocarcinoma cells (Ishikawa cell line), and human colon adenocarcinoma cells (DLD-1). The cells were maintained in DMEM supplemented with 10% FBS, 2 mmol/L glutamine, 50 U/mL penicillin, 50 μg/mL streptomycin at 37 °C in a 5% CO 2 incubator. Fibroblasts were counted in a hemocytometer and cultured at 1 · 10 5 cells/well in 2 mL of growth medium in 6-well plates (Costar, Salt Lake City, USA). Cells reached confl uence at day 6, and in most cases such cells were used for assays. Fibroblasts were used from the 8th to the 14th passage. Cancer cell lines were cultured at 1 · 10 5 cells/well in 2 mL of growth medium until reaching 80% confl uence.
Cell viability assay: The assay was performed according to the method of Carmichael et al. (1987) using MTT. The cells were cultured for 22 h with various concentrations of essential oil in 6-well plates, washed three times with PBS, and then incubated for 4 h in 1 mL of MTT solution (0.5 mg/mL of PBS) at 37 °C. The medium was removed and 1 mL of 0.1 M HCl in absolute isopropanol was added to the attached cells. Absorbance of the converted dye in living cells was measured at a wavelength of 570 nm. Cell viability in the presence of essential oil was calculated as percent of control cells.
Antifungal activity
The antifungal activity of essential oils was tested using the method described by Ðor evi et al. (2007) with minor modifi cations. Twenty fi ve strains (in equal numbers) belonging to the following species of fungi: Candida albicans, C. glabrata, C. tropicalis, C. krusei, and C. parapsilosis were randomly chosen for the examination. C. parapsilosis ATCC 22019 strain was included as a control strain.
Minimal inhibitory concentration (MIC) of essential oils was determined using the microdilution method in 96-well microtiter plates. Series of solutions of essential oils ranging from 30 to 0.4 μL/mL were prepared. Oil was dissolved in DMSO, and the solution was then diluted with Sabouraud dextrose broth supplemented with Tween 80 (fi nal content of 5 μL/mL). Test strains were suspended in Sabouraud broth to give a final density of 5 · 10 4 CFU/mL. Dilutions of oils and suspensions of fungi were inoculated on microtiter plates, adding growth control, sterility control, and oil solution controls. Plates were incubated under normal atmospheric conditions at 30 °C for 48 h. Minimal fungicidal concentrations (MFC) were also determined. For this purpose, 5 μL of essential oils were transferred from each well of the microtiter plate onto Sabouraud agar. Plates were incubated in the same conditions as microtiter plates and MFC values were read.
Statistical analysis
Mean values of three independent experiments done in duplicate ± standard deviation (SD) were calculated. The results were submitted to statistical analysis using Student's t-test, accepting P < 0.05 as signifi cant.
